Objective: To analyse potential molecular mechanisms and identify potential therapeutic regimens and drugs to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Crohn s disease (CD) through bioinformatics and systems biology. Study Design: Bioinformatics Study. Place and Duration of the Study:Jiading District Central Hospital A liated Shanghai University of Medicine & Health Sciences, Shanghai, China, from May to December 2022. Methodology: The common di erentially expressed genes (DEGs) between CD andSARS-CoV-2 infection were identi ed using two RNAseq datasets (GSE147507, GSE153974) extracted from Gene Expression Omnibus (GEO). Subsequently, functional enrichment, pathway analysis, and candidate drug analysis were performed using these DEGs. Results: In total, 44 DEGs were identi ed as common between CD andSARS-CoV-2 infection. A protein-protein interaction (PPI) network was constructed, hub genes were identi ed, and critical modules were determined by means of bioinformatics and combinatorial statistical approaches. Functional and pathway analyses conducted under ontological conditions showed a common association between CD and infection with SARS-CoV-2. The common DEGs were then used to identify coregulatory networks of interactions between transcriptional factors and genes, between proteins and medicines, and between DEGs and miRNAs. Conclusion: Top 10 hub genes includingIL6, CXCL1, CSF2, CXCL2, CXCL5, MMP3, PTGS2, CXCL3, SELE,and LCN2 were identi ed, which may function as potential candidate targets forSARS-CoV-2 infection. Additionally, the identi cation of certain promising treatment drugs for patients with SARS-CoV-2 infection and CD was also made.